AMAG Pharmaceuticals SMA 200
What is the SMA 200 of AMAG Pharmaceuticals?
The SMA 200 of AMAG Pharmaceuticals, Inc. is $14 +45.00%
What is the definition of SMA 200?
SMA 200 is an average stock price from the last 200 days calculated as an unweighted mean of the previous 200 stock closing prices.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 of companies in the Health Care sector on NASDAQ compared to AMAG Pharmaceuticals
What does AMAG Pharmaceuticals do?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Companies with sma 200 similar to AMAG Pharmaceuticals
- Takeda Pharmaceutical Co has SMA 200 of $14 +7.40%
- Delaware Investments Minnesota Municipal Income Fund II Inc has SMA 200 of $14 -2.92%
- comScore has SMA 200 of $14 -111.26%
- Carter Bankshares Inc has SMA 200 of $14 +20.42%
- Eaton Vance Tax-Managed Buy-Write Income Fund has SMA 200 of $14 +2.80%
- Wereldhave N.V has SMA 200 of €14 +6.35%
- AMAG Pharmaceuticals has SMA 200 of $14 +45.00%
- Opera Ltd has SMA 200 of $14 +3.04%
- CT Real Estate Investment Trust has SMA 200 of CAD$14 +13.06%
- Ark Restaurants has SMA 200 of $14 -16.68%
- F.N.B has SMA 200 of $14 +0.05%
- comScore has SMA 200 of $14 -111.90%
- comScore has SMA 200 of $14 -111.90%